NCT06735781Completed
Clinical Outcomes of Patients With Resectable Non-Small Cell Lung Cancer Receiving Neoadjuvant Nivolumab Plus Chemotherapy in France
Short-term Clinical Outcomes of Patients With Resectable Non-Small Cell Lung Cancer Receiving Nivolumab Plus Chemotherapy as Neoadjuvant Therapy in France
Source: ClinicalTrials.gov · Last updated 16 Dec 2024
Brief summary (registry, in English)
The purpose of this study is to evaluate real-world effectiveness of neoadjuvant nivolumab plus chemotherapy in France.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 101 (actual)
- First submitted
- 11 Dec 2024
- Start date
- Sept 2024
- Primary completion date
- Oct 2024
- Lead sponsor
- Bristol-Myers Squibb
- Diseases
- Lung cancer
- NCT number
- NCT06735781
What you commit to
- Study type: Observational
- Participants enrolled: 101
- From Sept 2024 to the primary completion date, Oct 2024
- 7 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having any primary tumor other than NSCLC on or before the date of NSCLC diagnosis that required a treatment ending less than 12-months before the nivolumab plus chemotherapy neoadjuvant treatment
Who the study is looking for
- Having a diagnosis of resectable non-small cell lung cancer (NSCLC)
- Being 18 years or above at the time of their NSCLC diagnosis
- Having initiated a neoadjuvant treatment with nivolumab and chemotherapy outside a clinical trial
- Being indexed in the site database
- Being followed at the site for at least 5 months, except for patients with a record of death
Age in the registry: 18 years to - · Sex: All
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre François Baclesse Coordinator of this site? Confirm its status | Caen | France | Unknown status |
| Centre Leon Berard Coordinator of this site? Confirm its status | Lyon | France | Unknown status |
| Hospices Civils de Lyon Coordinator of this site? Confirm its status | Lyon | France | Unknown status |
| Hôpital Robert Schuman Coordinator of this site? Confirm its status | Metz | France | Unknown status |
| Institut du Cancer de Montpellier Coordinator of this site? Confirm its status | Montpellier | France | Unknown status |
| Institute Curie Coordinator of this site? Confirm its status | Paris | France | Unknown status |
| Hôpital d'Instruction des Armées Saint-Anne Coordinator of this site? Confirm its status | Toulon | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.